HomeAMPH • NASDAQ
add
Amphastar Pharmaceuticals Inc
Previous close
$50.78
Day range
$50.04 - $51.35
Year range
$36.56 - $65.92
Market cap
2.46B USD
Avg Volume
292.42K
P/E ratio
16.10
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 182.39M | 25.17% |
Operating expense | 39.95M | 11.46% |
Net income | 37.95M | 45.26% |
Net profit margin | 20.81 | 16.06% |
Earnings per share | 0.94 | 44.62% |
EBITDA | 68.36M | 59.01% |
Effective tax rate | 24.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 217.78M | 33.49% |
Total assets | 1.49B | 8.22% |
Total liabilities | 778.18M | -1.38% |
Total equity | 713.35M | — |
Shares outstanding | 48.68M | — |
Price to book | 3.49 | — |
Return on assets | 9.01% | — |
Return on capital | 10.48% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 37.95M | 45.26% |
Cash from operations | 69.11M | 25.83% |
Cash from investing | -69.90M | 86.26% |
Cash from financing | -10.72M | -102.50% |
Net change in cash | -11.53M | 54.91% |
Free cash flow | -71.60M | -146.43% |
About
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally.
In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case.
In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
Founded
May 2004
Headquarters
Website
Employees
1,761